Immunomonitoring of Tacrolimus in healthy volunteers
Phase of Trial: Phase I/II
Latest Information Update: 04 Oct 2018
Price : $35 *
At a glance
- Drugs Tacrolimus (Primary)
- Indications Allergic conjunctivitis; Atopic dermatitis; Coronary artery restenosis; Eye disorders; Graft-versus-host disease; Interstitial lung diseases; Intestinal transplant rejection; Lupus nephritis; Myasthenia gravis; Open-angle glaucoma; Psoriasis; Rheumatoid arthritis; Transplant rejection; Ulcerative colitis
- Focus Pharmacodynamics; Pharmacokinetics
- 28 Sep 2018 Status changed from active, no longer recruiting to completed.
- 02 Sep 2018 Status changed from recruiting to active, no longer recruiting.
- 08 Aug 2018 New trial record